Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats

被引:9
作者
Bae, Woong Jin [1 ]
Ha, U. Syn [2 ]
Choi, Jin Bong [2 ]
Kim, Kang Sup [2 ]
Kim, Su Jin [2 ]
Cho, Hyuk Jin [2 ]
Hong, Sung Hoo [2 ]
Lee, Ji Youl [2 ]
Wang, Zhiping [3 ]
Hwang, Sung Yeoun [4 ]
Kim, Sae Woong [2 ]
机构
[1] Catholic Univ Korea, Coll Med, Catholic Integrat Med Res Inst, Seoul 06591, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Urol, 222 Banpo Daero, Seoul 06591, South Korea
[3] Lanzhou Univ, Dept Urol, Hosp 2, Lanzhou 730000, Peoples R China
[4] Korea Bio Med Sci Inst, Seoul, South Korea
关键词
Antioxidants; Hypogonadism; Phytotherapy; Testosterone; Urinary bladder; URINARY-TRACT SYMPTOMS; LATE-ONSET HYPOGONADISM; MIDDLE-AGED MEN; TESTOSTERONE UNDECANOATE; SERUM TESTOSTERONE; ELDERLY-MEN; CONTRACTION; DYSFUNCTION; HORMONES; THERAPY;
D O I
10.5534/wjmh.2015.33.2.73
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Purpose: We investigated the protective effects of the herbal formulation KH-204 in the bladder of androgen-deprived rats. Materials and Methods: Male rats aged eight weeks were randomly divided into four groups, containing eight rats each: sham operation only (normal control group), androgen-deprived only (androgen-deprived control group), and androgen-deprived followed by treatment with 200 mg/kg or 400 mg/kg of KH-204. After 0.5 mg/kg of leuprorelin was subcutaneously injected in the androgen-deprived groups, the oral administration of either distilled water in the two control groups or KH-204 in the treatment group was continued for four weeks. Serum testosterone levels, RhoGEF levels, nitric oxide (NO)-cyclic guanosine monophosphate (cGMP)-related parameters, oxidative stress, and histologic changes were evaluated after treatment. Results: Treatment with the herbal formulation KH-204 (1) increased serum testosterone levels; (2) restored the expression of RhoGEFs, endothelial NO synthase, and neuronal NO synthase; (3) increased the expression of superoxide dismutase; and (4) decreased bladder fibrosis. Conclusions: Our results suggest that the positive effects of KH-204 on the urinary bladder may be attributed to its antioxidant effects or to an elevation in NO-cGMP activity.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 28 条
[1]   Effects of KH-204 on the expression of heat shock protein 70 and germ cell apoptosis in infertility rat models [J].
Bae, Woong Jin ;
Ha, U. Syn ;
Kim, Kang Sup ;
Kim, Su Jin ;
Cho, Hyuk Jin ;
Hong, Sung Hoo ;
Lee, Ji Youl ;
Wang, Zhiping ;
Hwang, Sung Yeoun ;
Kim, Sae Woong .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
[2]   Testosterone replacement therapy and the risk of prostate cancer. Is there a link? [J].
Barqawi, A. ;
Crawford, E. D. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (04) :323-328
[3]   Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction [J].
Christ, GJ ;
Hodges, S .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 :S41-S55
[4]   EFFECT OF AGE ON INVIVO URINARY-BLADDER FUNCTION IN THE RAT [J].
CHUN, AL ;
WALLACE, LJ ;
GERALD, MC ;
LEVIN, RM ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1988, 139 (03) :625-627
[5]  
Dröge W, 2003, ADV EXP MED BIOL, V543, P191
[6]   NITRIC-OXIDE SYNTHASE ACTIVITY IN THE HUMAN UROGENITAL TRACT [J].
EHREN, I ;
ADOLFSSON, J ;
WIKLUND, NP .
UROLOGICAL RESEARCH, 1994, 22 (05) :287-290
[7]   Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study [J].
Feldman, HA ;
Longcope, C ;
Derby, CA ;
Johannes, CB ;
Araujo, AB ;
Coviello, AD ;
Bremner, WJ ;
McKinlay, JB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :589-598
[8]   Urodynamic effects of once-daily tadalafil in men with LUTS secondary to clinical BPH [J].
Gomelsky A. ;
Dmochowski R.R. .
Current Urology Reports, 2010, 11 (4) :254-260
[9]  
GOOREN LJG, 1994, J ANDROL, V15, P212
[10]   Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels [J].
Gotanda, K ;
Shinbo, A ;
Okada, M ;
Nakano, Y ;
Kobayashi, H ;
Sasaki, T ;
Hagiwara, M ;
Akaza, H .
PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (01) :66-72